Postinjury serum secretory phospholipase A2 correlates with hypoxemia and clinical status at 72 hours

被引:19
作者
Neidlinger, NA
Hirvela, ER
Skinner, RA
Larkin, SK
Harken, AH
Kuypers, FA
机构
[1] Univ Calif San Francisco, Dept Surg, Oakland, CA 94602 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA
[3] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA
关键词
D O I
10.1016/j.jamcollsurg.2004.10.010
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Although trauma patients often suffer direct lung damage, an equally destructive mechanism of lung injury involves postinjury systemic inflammation. We postulate that secretory phospholipase A, (sPLA,) release induced by trauma relates to systemic inflammation that compromises both lung function and clinical status after injury. The objectives of this study were: to relate Injury Severity Score to postinjury sPLA(2); to determine whether circulating sPLA, relates to pulmonary oxygenation and compliance; and to determine whether early or persistent increases in sPLA, are associated with abnormal chest x-ray at 72 hours after injury. STUDY DESIGN: The prospective cohort study comprised 54 consecutive intensive care admissions in patients with traumatic injury admitted over a 6-month period from November 1, 1996, to May 1, 1997. RESULTS: Postinjury peak sPLA(2) values were associated with increased ISS (r = 0.49, r(2) = 0.24, p < 0.001). Patients with elevated sPLA(2) had poor oxygenation compared with those with normal sPLA(2) levels (Pa0(2)/Fi0(2) ratio 164 +/- 16 versus 260 +/- 26 mmHg [mean +/- SEM], p < 0.01) and also required additional PEEP (5.5 +/- 0.9 versus 2.5 +/- 0.4 cm H2O, P = 0.01) Secretory PLA(2) levels in patients with abnormal chest x-ray 72 hours after injury were higher (1.08 +/- 0.2 versus 0.34 +/- 0.1 activity units, p < 0.001) than levels seen in patients with normal x-rays. CONCLUSIONS: Increasing injury magnitude is associated with elevated sPLA(2) levels, and increased sPLA(2) is related to postinjury hypoxemia and clinical status. (C) 2005 by the American College of Surgeons.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 20 条
[1]   Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure [J].
Abraham, E ;
Naum, C ;
Bandi, V ;
Gervich, D ;
Lowry, SF ;
Wunderink, R ;
Schein, RM ;
Macias, W ;
Skerjanec, S ;
Dmitrienko, A ;
Farid, N ;
Forgue, ST ;
Jiang, F .
CRITICAL CARE MEDICINE, 2003, 31 (03) :718-728
[2]   Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction [J].
Arbibe, L ;
Koumanov, K ;
Vial, D ;
Rougeot, C ;
Faure, G ;
Havet, N ;
Longacre, S ;
Vargaftig, BB ;
Béréziat, G ;
Voelker, DR ;
Wolf, C ;
Touqui, L .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (06) :1152-1160
[3]   SERUM PHOSPHOLIPASE-A2 ACTIVITY IN ACUTE-PANCREATITIS - AN EARLY GUIDE TO SEVERITY [J].
BIRD, NC ;
GOODMAN, AJ ;
JOHNSON, AG .
BRITISH JOURNAL OF SURGERY, 1989, 76 (07) :731-732
[4]   Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. [J].
Brower, RG ;
Matthay, MA ;
Morris, A ;
Schoenfeld, D ;
Thompson, BT ;
Wheeler, A ;
Wiedemann, HP ;
Arroliga, AC ;
Fisher, CJ ;
Komara, JJ ;
Perez-Trepichio, P ;
Parsons, PE ;
Wolkin, R ;
Welsh, C ;
Fulkerson, WJ ;
MacIntyre, N ;
Mallatratt, L ;
Sebastian, M ;
McConnell, R ;
Wilcox, C ;
Govert, J ;
Thompson, D ;
Clemmer, T ;
Davis, R ;
Orme, J ;
Weaver, L ;
Grissom, C ;
Eskelson, M ;
Young, M ;
Gooder, V ;
McBride, K ;
Lawton, C ;
d'Hulst, J ;
Peerless, JR ;
Smith, C ;
Brownlee, J ;
Pluss, W ;
Kallet, R ;
Luce, JM ;
Gottlieb, J ;
Elmer, M ;
Girod, A ;
Park, P ;
Daniel, B ;
Gropper, M ;
Abraham, E ;
Piedalue, F ;
Glodowski, J ;
Lockrem, J ;
McIntyre, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1301-1308
[5]  
DURHAM SK, 1990, AM J PATHOL, V136, P1283
[6]   CLINICAL RISKS FOR DEVELOPMENT OF THE ACUTE RESPIRATORY-DISTRESS SYNDROME [J].
HUDSON, LD ;
MILBERG, JA ;
ANARDI, D ;
MAUNDER, RJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (02) :293-301
[7]   BRONCHOALVEOLAR LAVAGE FLUID PHOSPHOLIPASE A(2) ACTIVITIES ARE INCREASED IN HUMAN ADULT-RESPIRATORY-DISTRESS-SYNDROME [J].
KIM, DK ;
FUKUDA, T ;
THOMPSON, BT ;
COCKRILL, B ;
HALES, C ;
BONVENTRE, JV .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 269 (01) :L109-L118
[8]   Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland [J].
Luhr, OR ;
Antonsen, K ;
Karlsson, M ;
Aardal, S ;
Thorsteinsson, A ;
Frostell, CG ;
Bonde, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (06) :1849-1861
[9]   IMPROVED SURVIVAL OF PATIENTS WITH ACUTE RESPIRATORY-DISTRESS-SYNDROME (ARDS) - 1983-1993 [J].
MILBERG, JA ;
DAVIS, DR ;
STEINBERG, KP ;
HUDSON, LD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (04) :306-309
[10]  
PATRICK DA, 2001, CRIT CARE MED, V29, P989